Sudomotor dysfunction is associated with foot ulceration in diabetes.
Diabet Med. 2009.
PMID: 19317826
Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2008 | 2 |
| 2009 | 4 |
| 2013 | 1 |
| 2022 | 0 |
Search Results
5
results
Results by year
Citations
1 article found by citation matchingSearch results
Filters applied: . Clear all
Page 1
Intensification of diabetes medication and risk for 30-day readmission.
Diabet Med. 2013 Feb;30(2):e56-62. doi: 10.1111/dme.12061.
Diabet Med. 2013.
PMID: 23126686
Free PMC article.
The association of glucose therapy intensification with subsequent 30-day risk for unplanned readmission/emergency department admission was examined, with focus on medicine service patients with poorly controlled glycaemia (baseline HbA(1c) 64 mmol/mol). ...Overall, glucos …
The association of glucose therapy intensification with subsequent 30-day risk for unplanned readmission/emergency department admission was …
Impaired islet turnover in human donor pancreata with aging.
Eur J Endocrinol. 2009 Feb;160(2):185-91. doi: 10.1530/EJE-08-0596. Epub 2008 Nov 12.
Eur J Endocrinol. 2009.
PMID: 19004984
RESULTS: Relative beta-cell volume in human pancreata (mean 2.3+/-0.2%) remains constant with aging (r=0.26, P=ns). Beta-cell replication (r=0.71, P=0.0004) decreases age-dependently, while beta-cell apoptosis does not change significantly (r=0.42, P=0.08). ...The rate of …
RESULTS: Relative beta-cell volume in human pancreata (mean 2.3+/-0.2%) remains constant with aging (r=0.26, P=ns). Beta-cell replica …
Sudomotor dysfunction is associated with foot ulceration in diabetes.
Diabet Med. 2009 Mar;26(3):302-5. doi: 10.1111/j.1464-5491.2009.02677.x.
Diabet Med. 2009.
PMID: 19317826
CONCLUSIONS: Sudomotor dysfunction is associated with increased risk of FU and should be included in the screening tests for identification of diabetic patients at risk of ulceration....
CONCLUSIONS: Sudomotor dysfunction is associated with increased risk of FU and should be included in the screening tests for identification …
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes.
Diabet Med. 2009 Jun;26(6):649-54. doi: 10.1111/j.1464-5491.2009.02748.x.
Diabet Med. 2009.
PMID: 19538242
Metformin serum levels were significantly lower (P < 0.001) after SMM than fasting (AUC(0-4 h) 350 +/- 66 vs. 457 +/- 55 mg/ml/min). CONCLUSION: Metformin inhibits DPP-4 activity in Type 2 diabetic patients in the fasting state but not when taken with a standard mixed m
…Metformin serum levels were significantly lower (P < 0.001) after SMM than fasting (AUC(0-4 h) 350 +/- 66 vs. 457 +/- 55 mg/ml/min). CONC
…
The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):175-80. doi: 10.1055/s-0028-1087177. Epub 2008 Dec 3.
Exp Clin Endocrinol Diabetes. 2009.
PMID: 19053032
Metformin also achieved a greater reduction in total cholesterol and LDL-C levels (metformin vs. non-metformin treated subjects: -31.9 vs. -17.3 mg/dl, p=0.001, and -26.2 vs. -15.9 mg/dl, p=0.006, respectively). CONCLUSIONS: Metformin reduces the occurrence of T (2)DM in o …
Metformin also achieved a greater reduction in total cholesterol and LDL-C levels (metformin vs. non-metformin treated subjects: -31.9 vs. - …
Cite